Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
Open Access
- 1 September 1996
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 348 (9028), 633-638
- https://doi.org/10.1016/s0140-6736(96)03487-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with WarfarinAnnals of Internal Medicine, 1996
- Bleeding During Antithrombotic Therapy in Patients With Atrial FibrillationArchives of Internal Medicine, 1996
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995
- Oral Anticoagulants and Intracranial HemorrhageStroke, 1995
- Anticoagulation in Atrial FibrillationArchives of Internal Medicine, 1994
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of Internal Medicine, 1994
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationThe New England Journal of Medicine, 1992
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989